{"id":44824,"date":"2022-06-07T23:01:30","date_gmt":"2022-06-07T21:01:30","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\/"},"modified":"2022-06-07T23:01:30","modified_gmt":"2022-06-07T21:01:30","slug":"viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\/","title":{"rendered":"VIQ Solutions Announces Voting Results From Annual and Special Meeting of Shareholders"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\nBoard and Management Acquired Approximately 135,000 Shares of VIQ Solutions Through Open Market Purchases\n<\/p>\n<p>PHOENIX, Ariz.&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fviqsolutions.com&amp;esheet=52742654&amp;newsitemid=20220607006258&amp;lan=en-US&amp;anchor=VIQ+Solutions+Inc&amp;index=1&amp;md5=9b3c619540dd67c55b4bb7f06496514c\" rel=\"nofollow noopener\" shape=\"rect\">VIQ Solutions Inc<\/a>. (\u201cVIQ\u201d or the \u201cCompany\u201d) (TSX: VQS and Nasdaq: VQS), a global provider of secure, AI-driven, digital voice and video capture technology and transcription services, announced the voting results from its annual and special meeting of shareholders (the \u201cMeeting\u201d) on June 7th, 2022. Shareholders approved all matters set forth in the Company&#8217;s Management Information Circular dated April 29th, 2022. A total of 19,097,117 common shares of the Company (the \u201cShares\u201d) were voted at the Meeting, representing 63.9% of the issued and outstanding Shares.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220607006258\/en\/749168\/5\/VIQ_Blue_Inline_ClearBG_512_%401x.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220607006258\/en\/749168\/21\/VIQ_Blue_Inline_ClearBG_512_%401x.jpg\"><\/a><\/p>\n<p>\nAdditionally, management announced that the members of the Company\u2019s board of directors and management purchased approximately 135,000 Shares. The Shares were purchased on the open market between May 13, 2022, and June 6 , 2022. As a result of these purchases, board members and management beneficially own approximately 6.75 million shares, representing approximately 22.6% of the total issued and outstanding Shares of VIQ.\n<\/p>\n<p>\n\u201cAfter emerging from one of the longest blackout periods in VIQ\u2019s history, Company insiders were able to purchase Shares in the open market,&#8221; stated Sebastien Par\u00e9, VIQ\u2019s Chief Executive Officer. \u201cWe are very optimistic about the future of the Company and are well-positioned to achieve our goals of at least $50M in revenue for the year.\u201d\n<\/p>\n<p>\n\u201cVIQ has transformed the way complex, multi-speaker content is managed and there is no doubt that this is our time,\u201d said Susan Sumner, VIQ\u2019s President and Chief Operating Officer. \u201cOur end-to-end technology and services portfolio has become even more strategic and relevant to our client base as we provide them with the solutions they need to combat post-pandemic resource and backlog challenges. The seamless integration of high-quality content capture, seamless workflow tools, real-time speech to text, and accurate edited documents creates efficiency and value, as well as increased transparency, usability of discrete data and overall accessibility of information for our diverse global client base.\u201d\n<\/p>\n<p>\nThe voting results for the election of directors were as follows:\n<\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl\" style=\"width:510px;\">\n<tr>\n<td class=\"bwvertalignb bwtopsingle bwsinglebottom bwleftsingle bwrightsingle bwpadl0\" colspan=\"1\" rowspan=\"1\" style=\"width:196px;\">\n<p class=\"bwalignc bwcellpmargin\">\nNominee\n<\/p>\n<\/td>\n<td class=\"bwvertalignb bwtopsingle bwsinglebottom bwrightsingle bwpadl0\" colspan=\"1\" rowspan=\"1\" style=\"width:142px;\">\n<p class=\"bwalignc bwcellpmargin\">\n% of votes for\n<\/p>\n<\/td>\n<td class=\"bwvertalignb bwtopsingle bwsinglebottom bwrightsingle bwpadl0\" colspan=\"1\" rowspan=\"1\" style=\"width:174px;\">\n<p class=\"bwalignc bwcellpmargin\">\n% of votes withheld\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignb bwsinglebottom bwleftsingle bwrightsingle bwpadl0\" colspan=\"1\" rowspan=\"1\" style=\"width:196px;\">\n<p class=\"bwcellpmargin\">\nSebastien Pare\n<\/p>\n<\/td>\n<td class=\"bwvertalignb bwsinglebottom bwrightsingle bwpadl0 bwpadr0\" colspan=\"1\" rowspan=\"1\" style=\"width:142px;\">\n<p class=\"bwalignr bwcellpmargin\">\n97.1%\n<\/p>\n<\/td>\n<td class=\"bwvertalignb bwsinglebottom bwrightsingle bwpadl0 bwpadr0\" colspan=\"1\" rowspan=\"1\" style=\"width:174px;\">\n<p class=\"bwalignr bwcellpmargin\">\n2.9%\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignb bwsinglebottom bwleftsingle bwrightsingle bwpadl0\" colspan=\"1\" rowspan=\"1\" style=\"width:196px;\">\n<p class=\"bwcellpmargin\">\nLarry Taylor\n<\/p>\n<\/td>\n<td class=\"bwvertalignb bwsinglebottom bwrightsingle bwpadl0 bwpadr0\" colspan=\"1\" rowspan=\"1\" style=\"width:142px;\">\n<p class=\"bwalignr bwcellpmargin\">\n97.1%\n<\/p>\n<\/td>\n<td class=\"bwvertalignb bwsinglebottom bwrightsingle bwpadl0 bwpadr0\" colspan=\"1\" rowspan=\"1\" style=\"width:174px;\">\n<p class=\"bwalignr bwcellpmargin\">\n2.9%\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignb bwsinglebottom bwleftsingle bwrightsingle bwpadl0\" colspan=\"1\" rowspan=\"1\" style=\"width:196px;\">\n<p class=\"bwcellpmargin\">\nHarvey Gordon\n<\/p>\n<\/td>\n<td class=\"bwvertalignb bwsinglebottom bwrightsingle bwpadl0 bwpadr0\" colspan=\"1\" rowspan=\"1\" style=\"width:142px;\">\n<p class=\"bwalignr bwcellpmargin\">\n91.0%\n<\/p>\n<\/td>\n<td class=\"bwvertalignb bwsinglebottom bwrightsingle bwpadl0 bwpadr0\" colspan=\"1\" rowspan=\"1\" style=\"width:174px;\">\n<p class=\"bwalignr bwcellpmargin\">\n9.0%\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignb bwsinglebottom bwleftsingle bwrightsingle bwpadl0\" colspan=\"1\" rowspan=\"1\" style=\"width:196px;\">\n<p class=\"bwcellpmargin\">\nSusan Sumner\n<\/p>\n<\/td>\n<td class=\"bwvertalignb bwsinglebottom bwrightsingle bwpadl0 bwpadr0\" colspan=\"1\" rowspan=\"1\" style=\"width:142px;\">\n<p class=\"bwalignr bwcellpmargin\">\n96.3%\n<\/p>\n<\/td>\n<td class=\"bwvertalignb bwsinglebottom bwrightsingle bwpadl0 bwpadr0\" colspan=\"1\" rowspan=\"1\" style=\"width:174px;\">\n<p class=\"bwalignr bwcellpmargin\">\n3.7%\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignb bwsinglebottom bwleftsingle bwrightsingle bwpadl0\" colspan=\"1\" rowspan=\"1\" style=\"width:196px;\">\n<p class=\"bwcellpmargin\">\nChristine Fellowes\n<\/p>\n<\/td>\n<td class=\"bwvertalignb bwsinglebottom bwrightsingle bwpadl0 bwpadr0\" colspan=\"1\" rowspan=\"1\" style=\"width:142px;\">\n<p class=\"bwalignr bwcellpmargin\">\n97.1%\n<\/p>\n<\/td>\n<td class=\"bwvertalignb bwsinglebottom bwrightsingle bwpadl0 bwpadr0\" colspan=\"1\" rowspan=\"1\" style=\"width:174px;\">\n<p class=\"bwalignr bwcellpmargin\">\n2.9%\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignb bwsinglebottom bwleftsingle bwrightsingle bwpadl0\" colspan=\"1\" rowspan=\"1\" style=\"width:196px;\">\n<p class=\"bwcellpmargin\">\nJoseph Quarin\n<\/p>\n<\/td>\n<td class=\"bwvertalignb bwsinglebottom bwrightsingle bwpadl0 bwpadr0\" colspan=\"1\" rowspan=\"1\" style=\"width:142px;\">\n<p class=\"bwalignr bwcellpmargin\">\n97.1%\n<\/p>\n<\/td>\n<td class=\"bwvertalignb bwsinglebottom bwrightsingle bwpadl0 bwpadr0\" colspan=\"1\" rowspan=\"1\" style=\"width:174px;\">\n<p class=\"bwalignr bwcellpmargin\">\n2.9%\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignb bwsinglebottom bwleftsingle bwrightsingle bwpadl0\" colspan=\"1\" rowspan=\"1\" style=\"width:196px;\">\n<p class=\"bwcellpmargin\">\nYixin (Shing) Pan\n<\/p>\n<\/td>\n<td class=\"bwvertalignb bwsinglebottom bwrightsingle bwpadl0 bwpadr0\" colspan=\"1\" rowspan=\"1\" style=\"width:142px;\">\n<p class=\"bwalignr bwcellpmargin\">\n97.1%\n<\/p>\n<\/td>\n<td class=\"bwvertalignb bwsinglebottom bwrightsingle bwpadl0 bwpadr0\" colspan=\"1\" rowspan=\"1\" style=\"width:174px;\">\n<p class=\"bwalignr bwcellpmargin\">\n2.9%\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignb bwsinglebottom bwleftsingle bwrightsingle bwpadl0\" colspan=\"1\" rowspan=\"1\" style=\"width:196px;\">\n<p class=\"bwcellpmargin\">\nBradley Wells\n<\/p>\n<\/td>\n<td class=\"bwvertalignb bwsinglebottom bwrightsingle bwpadl0 bwpadr0\" colspan=\"1\" rowspan=\"1\" style=\"width:142px;\">\n<p class=\"bwalignr bwcellpmargin\">\n97.1%\n<\/p>\n<\/td>\n<td class=\"bwvertalignb bwsinglebottom bwrightsingle bwpadl0 bwpadr0\" colspan=\"1\" rowspan=\"1\" style=\"width:174px;\">\n<p class=\"bwalignr bwcellpmargin\">\n2.9%\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\nThe voting results for the remaining matters were as follows:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nFixing the number of directors to be elected at eight and authorizing the Board to determine the number of directors from time to time and the number of directors to be elected at annual meetings of the Company within the minimum and maximum number of directors set forth in the articles of the Company:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nVotes for: 99.9%\n<\/li>\n<li>\nVotes against: 0.1%\n<\/li>\n<\/ul>\n<\/li>\n<li>\nAppointing KPMG LLP Chartered Professional Accountants as auditor of the Company for the ensuing year and authorizing the Board to fix their remuneration:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nVotes for: 99.9%\n<\/li>\n<li>\nVotes withheld: 0.1%\n<\/li>\n<\/ul>\n<\/li>\n<li>\nApproving the Amended and restated By-Law No 1 of the Company:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nVotes for: 96.7%\n<\/li>\n<li>\nVotes against: 3.3%\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>\nFor further details on each of the above matters, please refer to the Circular available under VIQ\u2019s profile on the System for Electronic Document Analysis and Retrieval (SEDAR) at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedar.com&amp;esheet=52742654&amp;newsitemid=20220607006258&amp;lan=en-US&amp;anchor=www.sedar.com&amp;index=2&amp;md5=fcf9dda22d605c0acd048e40a9d3cbbe\" rel=\"nofollow noopener\" shape=\"rect\">www.sedar.com<\/a>.\n<\/p>\n<p>\nFinal voting results on all matters voted on at the Meeting will be filed on SEDAR at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedar.com&amp;esheet=52742654&amp;newsitemid=20220607006258&amp;lan=en-US&amp;anchor=www.sedar.com&amp;index=3&amp;md5=75de63f4e93abb829f579f7063cf8980\" rel=\"nofollow noopener\" shape=\"rect\">www.sedar.com<\/a>.\n<\/p>\n<p>\nFor more information about VIQ, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fviqsolutions.com&amp;esheet=52742654&amp;newsitemid=20220607006258&amp;lan=en-US&amp;anchor=viqsolutions.com&amp;index=4&amp;md5=67baaf41c9bf162a9660d6b8b12c5565\" rel=\"nofollow noopener\" shape=\"rect\">viqsolutions.com<\/a>.\n<\/p>\n<p>\n<b>About VIQ Solutions Inc.<\/b>\n<\/p>\n<p>\nVIQ Solutions is a global provider of secure, AI-driven, digital voice and video capture technology and transcription services. VIQ offers a seamless, comprehensive solution suite that delivers intelligent automation, enhanced with human review, to drive transformation in the way content is captured, secured, and repurposed into actionable information. The cyber-secure, AI technology and services platform are implemented in the most rigid security environments including criminal justice, legal, insurance, media, government, corporate finance, media, and transcription service provider markets, enabling them to improve the quality and accessibility of evidence, to easily identify predictive insights and to achieve digital transformation faster and at a lower cost.\n<\/p>\n<p>\nForward Looking-Statements\n<\/p>\n<p>\nCertain statements included in this press release constitute forward-looking statements or forward-looking information under applicable securities legislation. Such forward-looking statements or information are provided for the purpose of providing information about management&#8217;s current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes.\n<\/p>\n<p>\nForward-looking statements or information typically contain statements with words such as &#8220;anticipate&#8221;, &#8220;believe&#8221;, &#8220;expect&#8221;, &#8220;plan&#8221;, &#8220;intend&#8221;, &#8220;estimate&#8221;, &#8220;propose&#8221;, &#8220;project&#8221; or similar words, including negatives thereof, suggesting future outcomes or that certain events or conditions \u201cmay\u201d or \u201cwill\u201d occur. These statements are only predictions. Forward-looking statements or information in this press release include, but are not limited to Company\u2019s current focus and the ability of the Company to achieve its stated goals in the upcoming year.\n<\/p>\n<p>\nForward-looking statements or information are based on several factors and assumptions which have been used to develop such statements and information, but which may prove to be incorrect. Although VIQ believes that the expectations reflected in such forward-looking statements or information are reasonable, undue reliance should not be placed on forward-looking statements because VIQ can give no assurance that such expectations will prove to be correct. In addition to other factors and assumptions which may be identified in this press release, assumptions have been made regarding, among other things, recent initiatives and that sales and prospects may provide incremental value for shareholders. Readers are cautioned that the foregoing list is not exhaustive of all factors and assumptions that have been used.\n<\/p>\n<p>\nForward-looking information is necessarily based on a number of opinions, assumptions and estimates that while considered reasonable by the Company as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, included but not limited to the factors described in greater detail in the \u201cRisk Factors\u201d section of the Company\u2019s annual information form dated March 31, 2022, in the Company\u2019s annual report form on Form 20-F and in the Company\u2019s other materials filed with the Canadian securities regulatory authorities and the U.S. Securities and Exchange Commission from time to time, available at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedar.com&amp;esheet=52742654&amp;newsitemid=20220607006258&amp;lan=en-US&amp;anchor=www.sedar.com&amp;index=5&amp;md5=6fb667a88a541d3d9127259299042588\" rel=\"nofollow noopener\" shape=\"rect\">www.sedar.com<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=52742654&amp;newsitemid=20220607006258&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=6&amp;md5=3e0c13aaedef062500ef0619d07df27a\" rel=\"nofollow noopener\" shape=\"rect\">www.sec.gov<\/a>, respectively.\n<\/p>\n<p>\nThese factors are not intended to represent a complete list of the factors that could affect the Company, however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this press release are made as of the date of this press release and the Company expressly disclaims any obligations to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media Contact:<\/b><br \/>Laura Haggard<br \/>\n<br \/>Chief Marketing Officer<br \/>\n<br \/>VIQ Solutions Inc.<br \/>\n<br \/>Phone: (800) 263-9947<br \/>\n<br \/>Email: <a target=\"_blank\" href=\"mai&#108;&#116;&#111;&#58;&#x6d;&#x61;&#x72;&#x6b;&#x65;&#x74;&#x69;ng&#64;&#118;&#105;&#113;&#115;&#111;&#x6c;&#x75;&#x74;&#x69;&#x6f;&#x6e;s&#46;co&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#109;&#x61;r&#x6b;&#x65;&#116;&#x69;n&#103;&#x40;&#118;&#x69;q&#115;&#x6f;l&#x75;t&#105;&#x6f;n&#x73;&#x2e;&#99;&#x6f;m<\/a><\/p>\n<p><b>Investor Relations Contact:<\/b><br \/>Laura Kiernan<br \/>\n<br \/>High Touch Investor Relations<br \/>\n<br \/>Ph. 1-914-598-7733<br \/>\n<br \/>Email: <a target=\"_blank\" href=\"ma&#105;&#108;&#116;&#x6f;&#x3a;&#x76;&#x69;q&#64;&#104;&#116;&#105;&#x72;&#x2e;&#x6e;&#x65;t\" rel=\"nofollow noopener\" shape=\"rect\">&#118;&#x69;q&#x40;&#x68;&#116;&#x69;r&#46;&#x6e;&#101;&#x74;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Board and Management Acquired Approximately 135,000 Shares of VIQ Solutions Through Open Market Purchases PHOENIX, Ariz.&#8211;(BUSINESS WIRE)&#8211;VIQ Solutions Inc. (\u201cVIQ\u201d or the \u201cCompany\u201d) (TSX: VQS and Nasdaq: VQS), a global provider of secure, AI-driven, digital voice and video capture technology and transcription services, announced the voting results from its annual and special meeting of shareholders &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44824","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>VIQ Solutions Announces Voting Results From Annual and Special Meeting of Shareholders - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VIQ Solutions Announces Voting Results From Annual and Special Meeting of Shareholders - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Board and Management Acquired Approximately 135,000 Shares of VIQ Solutions Through Open Market Purchases PHOENIX, Ariz.&#8211;(BUSINESS WIRE)&#8211;VIQ Solutions Inc. (\u201cVIQ\u201d or the \u201cCompany\u201d) (TSX: VQS and Nasdaq: VQS), a global provider of secure, AI-driven, digital voice and video capture technology and transcription services, announced the voting results from its annual and special meeting of shareholders ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-07T21:01:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220607006258\/en\/749168\/21\/VIQ_Blue_Inline_ClearBG_512_%401x.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"VIQ Solutions Announces Voting Results From Annual and Special Meeting of Shareholders\",\"datePublished\":\"2022-06-07T21:01:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\\\/\"},\"wordCount\":1167,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220607006258\\\/en\\\/749168\\\/21\\\/VIQ_Blue_Inline_ClearBG_512_%401x.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\\\/\",\"name\":\"VIQ Solutions Announces Voting Results From Annual and Special Meeting of Shareholders - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220607006258\\\/en\\\/749168\\\/21\\\/VIQ_Blue_Inline_ClearBG_512_%401x.jpg\",\"datePublished\":\"2022-06-07T21:01:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220607006258\\\/en\\\/749168\\\/21\\\/VIQ_Blue_Inline_ClearBG_512_%401x.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220607006258\\\/en\\\/749168\\\/21\\\/VIQ_Blue_Inline_ClearBG_512_%401x.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VIQ Solutions Announces Voting Results From Annual and Special Meeting of Shareholders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VIQ Solutions Announces Voting Results From Annual and Special Meeting of Shareholders - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\/","og_locale":"en_US","og_type":"article","og_title":"VIQ Solutions Announces Voting Results From Annual and Special Meeting of Shareholders - Pharma Trend","og_description":"Board and Management Acquired Approximately 135,000 Shares of VIQ Solutions Through Open Market Purchases PHOENIX, Ariz.&#8211;(BUSINESS WIRE)&#8211;VIQ Solutions Inc. (\u201cVIQ\u201d or the \u201cCompany\u201d) (TSX: VQS and Nasdaq: VQS), a global provider of secure, AI-driven, digital voice and video capture technology and transcription services, announced the voting results from its annual and special meeting of shareholders ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-07T21:01:30+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220607006258\/en\/749168\/21\/VIQ_Blue_Inline_ClearBG_512_%401x.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"VIQ Solutions Announces Voting Results From Annual and Special Meeting of Shareholders","datePublished":"2022-06-07T21:01:30+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\/"},"wordCount":1167,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220607006258\/en\/749168\/21\/VIQ_Blue_Inline_ClearBG_512_%401x.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\/","url":"https:\/\/pharma-trend.com\/en\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\/","name":"VIQ Solutions Announces Voting Results From Annual and Special Meeting of Shareholders - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220607006258\/en\/749168\/21\/VIQ_Blue_Inline_ClearBG_512_%401x.jpg","datePublished":"2022-06-07T21:01:30+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220607006258\/en\/749168\/21\/VIQ_Blue_Inline_ClearBG_512_%401x.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220607006258\/en\/749168\/21\/VIQ_Blue_Inline_ClearBG_512_%401x.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/viq-solutions-announces-voting-results-from-annual-and-special-meeting-of-shareholders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"VIQ Solutions Announces Voting Results From Annual and Special Meeting of Shareholders"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44824","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44824"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44824\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44824"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44824"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44824"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}